Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$4.58 - $6.8 $194,650 - $289,000
-42,500 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$5.23 - $7.18 $222,275 - $305,150
42,500 New
42,500 $273,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Difesa Capital Management, LP Portfolio

Follow Difesa Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Difesa Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Difesa Capital Management, LP with notifications on news.